We advised the placement agents on the transaction

Davis Polk advised the placement agents in connection with Novanta Inc.’s $300 million private placement of common shares.

Novanta is a leading global supplier of core technology solutions that give medical, life science and advanced industrial original equipment manufacturers a competitive advantage. Novanta combines deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges.

The Davis Polk capital markets team included partner Yasin Keshvargar and associate Walker Halstad. All members of the Davis Polk team are based in the New York office.

Copy link to share post